glp 1 drugs novo nordisk Nordisk's weight-loss pill wins FDA approval Novo Nordisk justifies reasoning behind
Description
There are several safety issues related to unapproved versions of GLP-1s
If manufacturers are able to develop orals that rival the clinical profile of injectables, the market could be flipped on its head
Oral tablets: Rybelsus, taken once daily
Researchers have found that differences in the GLP1RA gene , which encodes the GLP-1 receptor, influence how much weight someone is likely to lose on these medications
Related Reading How Can I Get Foundayo
